Interventional, randomised, prospective, monocentric study
Primary objective :
Demonstrate the interest of the homeopathic Protocol to reduce the onset or aggravation of joint pain as a result of the taking of AI compared to conventional care
Secondary objective :
Compare between the two treatment groups:
* Evolution of joint pain
* Evolution of joint stiffness-rate of onset of pain and joint stiffness-delay in onset or aggravation of pain-evolution of the number of painful locations-evolution of the impact of pain on the quality of the sleep-consumption of permitted concomitant treatments (analgesics)
* Evolution of symptoms of hormonal deprivation-adherence to AI treatment
* Tolerance to AI
* Change seen by patients
* Stop rate and switch of AI-rate of recurrence of breast cancer
Describe in patients receiving homeopathic treatment:
* Adherence to homeopathic treatment
* Tolerance to homeopathic treatment
* Group A: Group of patients receiving conventional treatment (drug analgesic class 1) for joint pain + homeopathic treatment
* Group B: Group of patients receiving conventional treatment (drug analgesic class 1) for joint pain
Schedule :
* Inclusions start at: 01/09/2018
* End date of inclusions: 01/09/2021
* End date of follow-up: 23/03/2022
* Study report: 23/03/2023
